EU Clinical Trials Register: useless? [Regulatives / Guidelines]

posted by Ohlbe – France, 2018-01-23 18:54 (1890 d 13:34 ago) – Posting: # 18280
Views: 7,872

Dear Helmut,

❝ #3: 12.8% of studies were inspected? Wow! Given that some studies with an assigned EudraCT number were never performed, the percentage is higher.

No. In a Phase 3 study they may have inspected several clinical sites, the sponsor, a central lab, a CRO... And several Member States may inspect the same trial. So I would expect the figure to be much lower.


Complete thread:

UA Flag
 Admin contact
22,557 posts in 4,724 threads, 1,606 registered users;
19 visitors (0 registered, 19 guests [including 8 identified bots]).
Forum time: 09:28 CEST (Europe/Vienna)

The function of genius is not to give new answers, but to pose
new questions which time and mediocrity can resolve.    H.R. Trevor-Roper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz